Fibrosing interstitial lung disease - A drug from the specified list Factor
Last reviewed for CCPS 16 December 2009.
Investigative Documents
Medical Report - Treatment with a Specified Drug [MR9422] Preliminary questions [40670]
40947 [2] the veteran has been treated with a drug from the specified list for fibrosing interstitial lung disease at some time. the veteran was treated with a drug from the specified list for fibrosing interstitial lung disease for treatment of an illness or injury which is identifiable. 40951 — the veteran has established the causal connection between treatment with a drug from the specified list and VEA service for fibrosing interstitial lung disease. 40952 — the veteran has established the causal connection between treatment with a drug from the specified list and VEA service for the clinical onset of fibrosing interstitial lung disease. 40954 — the veteran has established the causal connection between treatment with a drug from the specified list and operational service for the clinical onset of fibrosing interstitial lung disease. or 40955 — the veteran has established the causal connection between treatment with a drug from the specified list and eligible service for the clinical onset of fibrosing interstitial lung disease. or 40953 — the veteran has established the causal connection between treatment with a drug from the specified list and VEA service for the clinical worsening of fibrosing interstitial lung disease. 40956 — the veteran has established the causal connection between treatment with a drug from the specified list and operational service for the clinical worsening of fibrosing interstitial lung disease. or 40957 — the veteran has established the causal connection between treatment with a drug from the specified list and eligible service for the clinical worsening of fibrosing interstitial lung disease. Clinical onset and operational service [40954] 40958 — the identified illness or injury, for which the veteran was treated with a drug from the specified list for fibrosing interstitial lung disease, is causally related to operational service. [8] [9] Clinical onset and eligible service [40955] 40959 — the identified illness or injury, for which the veteran was treated with a drug from the specified list for fibrosing interstitial lung disease, is causally related to eligible service. [10] [9] Clinical worsening and operational service [40956] 40958 — the identified illness or injury, for which the veteran was treated with a drug from the specified list for fibrosing interstitial lung disease, is causally related to operational service. [11] [9] Clinical worsening and eligible service [40957] 40959 — the identified illness or injury, for which the veteran was treated with a drug from the specified list for fibrosing interstitial lung disease, is causally related to eligible service. [13] [9]
Links
[1] https://clik.dva.gov.au/ccpsmedical-194
[2] https://clik.dva.gov.au/ccpsh010rc-20
[3] clikpopup://CCPS/reject40947No
[4] clikpopup://CCPS/reject40948No
[5] clikpopup://CCPS/reject40949No
[6] clikpopup://CCPS/Reject/OnsetAfterService
[7] clikpopup://CCPS/Reject/NoPermanentWorsening
[8] clikpopup://CCPS/reject40950No
[9] clikpopup://CCPS/reject40958,40959No
[10] clikpopup://CCPS/reject40959No
[11] clikpopup://CCPS/reject40958No
[12] clikpopup://CCPS/Onset of FILD before Op service to which illness, for which had specified drug, is causally related
[13] clikpopup://CCPS/reject40960No
[14] clikpopup://CCPS/Onset of FILD before El service to which illness, for which had specified drug, is causally related
[15] clikpopup://CCPS/reject40961No